Table of Contents
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porterโs Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
6. GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE
6.1. Overview
6.2. Antifungal Product
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3. Corticosteroid Lotions
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4. Sulfur Products
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7. GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION
7.1. Overview
7.2. Oral
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3. Topical
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8. GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER
8.1. Overview
8.2. Hospital Pharmacies
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3. Retail Pharmacies
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.4. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9. GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET, BY REGION
9.1. Overview
9.2. Americas
9.2.1. North America
9.2.1.1. US
9.2.1.2. Canada
9.2.2. Latin America
9.3. Europe
9.3.1. Western Europe
9.3.1.1. Germany
9.3.1.2. France
9.3.1.3. Italy
9.3.1.4. Spain
9.3.1.5. UK
9.3.1.6. Rest of Western Europe
9.3.2. Eastern Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle East & Africa
9.5.1. Middle East
9.5.2. Africa
10. COMPANY LANDSCAPE
10.1.1. Overview
10.1.2. Competitive Analysis
11. COMPANY PROFILES
11.1. Sonoma Pharmaceuticals
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Key Developments
11.1.4. SWOT Analysis
11.1.5. Key Strategies
11.2. Merck
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Key Developments
11.2.4. SWOT Analysis
11.2.5. Key Strategies
11.3. Hikma Pharmaceuticals
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Key Developments
11.3.4. SWOT Analysis
11.3.5. Key Strategies
11.4. Allen and Hanburys
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Key Developments
11.4.4. SWOT Analysis
11.4.5. Key Strategies
11.5. GlaxoSmithKline
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Key Developments
11.5.4. SWOT Analysis
11.5.5. Key Strategies
11.6. Bausch Health
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Key Developments
11.6.4. SWOT Analysis
11.6.5. Key Strategies
11.7. Valent Pharmaceutical
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Key Developments
11.7.4. SWOT Analysis
11.7.5. Key Strategies
11.8. West-Ward Pharmaceutical Corp.
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Key Developments
11.8.4. SWOT Analysis
11.8.5. Key Strategies
11.9. Others
12. APPENDIX
12.1. References
12.2. Related Reportsโ
LIST OF TABLES
TABLE 1 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET SYNOPSIS, 2020-2027
TABLE 2 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)
TABLE 3 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)
TABLE 4 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 5 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 6 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 7 NORTH AMERICA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)
TABLE 8 NORTH AMERICA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 9 NORTH AMERICA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 10 US: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)
TABLE 11 US: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 12 US: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 13 CANADA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)
TABLE 14 CANADA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 15 CANADA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 16 LATIN AMERICA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)
TABLE 17 LATIN AMERICA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 18 LATIN AMERICA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 19 EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)
TABLE 20 EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 21 EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 22 WESTERN EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)
TABLE 23 WESTERN EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 24 WESTERN EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 25 EASTERN EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)
TABLE 26 EASTERN EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 27 EASTERN EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 28 ASIA-PACIFIC: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)
TABLE 29 ASIA-PACIFIC: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 30 ASIA-PACIFIC: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY TREATMENT TYPE, 2020-2027 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA: SEBORRHEIC DERMATITIS TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET
FIGURE 4 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE, BY TREATMENT TYPE, 2020 (%)
FIGURE 5 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE, BY ROUTE OF ADMINISTRATION, 2020 (%)
FIGURE 6 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE, BY END USER, 2020 (%)
FIGURE 7 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE, BY REGION, 2020 (%)
FIGURE 8 AMERICAS: SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE BY REGION, 2020 (%)
FIGURE 9 NORTH AMERICA: SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 10 EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE, BY REGION, 2020 (%)
FIGURE 11 WESTERN EUROPE: SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 12 ASIA-PACIFIC: SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 13 MIDDLE EAST & AFRICA: SEBORRHEIC DERMATITIS TREATMENT MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 14 GLOBAL SEBORRHEIC DERMATITIS TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 15 SONOMA PHARMACEUTICALS.: KEY FINANCIALS
FIGURE 16 SONOMA PHARMACEUTICALS: SEGMENTAL REVENUE
FIGURE 17 SONOMA PHARMACEUTICALS: REGIONAL REVENUE
FIGURE 18 MERCK: KEY FINANCIALS
FIGURE 19 MERCK: SEGMENTAL REVENUE
FIGURE 20 MERCK: REGIONAL REVENUE
FIGURE 21 HIKMA PHARMACEUTICALS: KEY FINANCIALS
FIGURE 22 HIKMA PHARMACEUTICALS: SEGMENTAL REVENUE
FIGURE 23 HIKMA PHARMACEUTICALS: REGIONAL REVENUE
FIGURE 24 ALLEN AND HANBURYS: KEY FINANCIALS
FIGURE 25 ALLEN AND HANBURYS: SEGMENTAL REVENUE
FIGURE 26 ALLEN AND HANBURYS: REGIONAL REVENUE
FIGURE 27 GLAXOSMITHKLINE: KEY FINANCIALS
FIGURE 28 GLAXOSMITHKLINE: SEGMENTAL REVENUE
FIGURE 29 GLAXOSMITHKLINE: REGIONAL REVENUE
FIGURE 30 BAUSCH HEALTH: KEY FINANCIALS
FIGURE 31 BAUSCH HEALTH: SEGMENTAL REVENUE
FIGURE 32 BAUSCH HEALTH: REGIONAL REVENUE
FIGURE 33 VALENT PHARMACEUTICAL: KEY FINANCIALS
FIGURE 34 VALENT PHARMACEUTICAL: SEGMENTAL REVENUE
FIGURE 35 VALENT PHARMACEUTICAL: REGIONAL REVENUE
FIGURE 36 WEST-WARD PHARMACEUTICAL CORP: KEY FINANCIALS
FIGURE 37 WEST-WARD PHARMACEUTICAL CORP: SEGMENTAL REVENUE
FIGURE 38 WEST-WARD PHARMACEUTICAL CORP: REGIONAL REVENUE